Neuroprotective Studies of Evodiamine in an Okadaic Acid-Induced Neurotoxicity
Background: Alzheimer’s disease (AD) is the most common neurodegenerative disease, and it manifests as progressive memory loss and cognitive decline. However, there are no effective therapies for AD, which is an urgent problem to solve. Evodiamine, one of the main bioactive ingredients of <i>E...
Main Authors: | Ching-Hsuan Chou, Chia-Ron Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/10/5347 |
Similar Items
-
Okadaic acid induces damage of human neuroblastoma cell line SH-SY5Y
by: LU Ya-lan, ZHOU Li, HAN Yun-lin, WANG Ke-wei, QIN Chuan
Published: (2022-06-01) -
Antitumor activity of 2 new evodiamine derivatives against small-cell lung cancer cells in vitro
by: JIANG Xuejun, et al.
Published: (2019-05-01) -
Use of Okadaic Acid to Identify Relevant Phosphoepitopes in Pathology: A Focus on Neurodegeneration
by: Jesús Avila, et al.
Published: (2013-05-01) -
Differential Hyperphosphorylation of Tau-S199, -T231 and -S396 in Organotypic Brain Slices of Alzheimer Mice. A Model to Study Early Tau Hyperphosphorylation Using Okadaic Acid
by: Bettina M. Foidl, et al.
Published: (2018-04-01) -
Simple Diffusion as the Mechanism of Okadaic Acid Uptake by the Mussel Digestive Gland
by: Juan Blanco, et al.
Published: (2019-07-01)